Shrewsbury, MA, United States of America

Craig Cameron Mello

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Gene Editing. Top assignees: University of Massachusetts, Carnegie Institution of Washington. Active years: 2003-2026. Nobel Prize laureate.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig Cameron Mello. Retrieved from https://idiyas.com/inventor/craig-c-mello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 38.1

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 1,711(Granted Patents)

Location History:

Boston, MA (US) (2012 - 2013)
Shrewsbury, MA (US) (2003 - 2019)
Barrington, RI (US) (2015 - 2024)

Company Filing History:

19 out of 1,638

University of Massachusetts

patents

9 out of 91

Carnegie Institution of Washington

patents

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Gene Editing

RNA Interference

Genetic Inhibition

Small Interfering RNAs

Double-Stranded RNA

Gene Silencing

Targeted Genetic Interference

In Vivo Production

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612619 - COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING (2026-04-28),

2. 11981892 - Compositions and methods for improved gene editing (2024-05-14),

3. 11873487 - Compositions and methods for improved gene editing (2024-01-16),

4. 10731155 - In vivo production of small interfering RNAs that mediate gene silencing (2020-08-04),

5. 10358653 - Genetic inhibition by double-stranded RNA (2019-07-23),

6. 9850487 - In vivo production of small interfering RNAs that mediate gene silencing (2017-12-26),

7. 9175287 - In vivo production of small interfering RNAs that mediate gene silencing (2015-11-03),

8. 9102939 - Genetic inhibition by double-stranded RNA (2015-08-11),

9. 8580754 - Genetic inhibition by double-stranded RNA (2013-11-12),

10. 8557785 - In vivo production of small interfering RNAS that mediate gene silencing (2013-10-15),

11. 8530438 - Vivo production of small interfering RNAs that mediate gene silencing (2013-09-10),

12. 8283329 - Genetic inhibition of double-stranded RNA (2012-10-09),

13. 8232260 - In vivo production of small interfering RNAs that mediate gene silencing (2012-07-31),

14. 7893036 - In vivo production of small interfering RNAs that mediate gene silencing (2011-02-22),

15. 7759463 - RNA interference pathway genes as tools for targeted genetic interference (2010-07-20),

Title: The Innovative Journey of Craig C. Mello

Introduction

Craig C. Mello, an influential inventor based in Shrewsbury, MA, has made significant contributions to the field of gene editing. With a remarkable portfolio of 20 patents, Mello's work enhances the precision and efficiency of genetic manipulation, marking him as a leader in biotechnology.

Latest Patents

Among his most recent patents are innovative compositions and methods for improved gene editing. These disclosures detail novel approaches to creating modified nucleic acid donor templates, which are crucial for achieving highly efficient and precise gene editing outcomes. Mello's inventions are paving the way for advancements in genetic research and therapeutic applications.

Career Highlights

Mello's career has been marked by his association with esteemed institutions. He has worked at the University of Massachusetts, where he contributed significant research to the field of genetics. Additionally, his collaboration with the Carnegie Institution of Washington has further enriched his expertise and impact on gene editing technologies.

Collaborations

Throughout his career, Craig C. Mello has had the opportunity to work alongside prominent colleagues such as Andrew Fire and Hiroaki Tabara. These collaborations have fueled innovative research and facilitated the exchange of ideas, leading to groundbreaking advancements in gene editing.

Conclusion

Craig C. Mello's contributions to the field of gene editing have not only resulted in a significant number of patents but have also opened new avenues in genetic research. His relentless pursuit of innovation continues to inspire future generations of inventors and researchers in the biotechnology sector.

Profile summary based on public USPTO records.